» Articles » PMID: 15465040

Metabolism of Vitamin D by Human Microsomal CYP2R1

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2004 Oct 7
PMID 15465040
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The activation of vitamin D requires 25-hydroxylation in the liver and 1alpha-hydroxylation in the kidney. However, it remains unclear which enzyme is relevant to vitamin D 25-hydroxylation. Recently, human CYP2R1 has been reported to be a potential candidate for a hepatic vitamin D 25-hydroxylase. Thus, vitamin D metabolism by CYP2R1 was compared with human mitochondrial CYP27A1, which used to be considered a physiologically important vitamin D(3) 25-hydroxylase. A clear difference was observed between CYP2R1 and CYP27A1 in the metabolism of vitamin D(2). CYP2R1 hydroxylated vitamin D(2) at the C-25 position while CYP27A1 hydroxylated it at positions C-24 and C-27. The K(m) and k(cat) values for the CYP2R1-dependent 25-hydroxylation activity toward vitamin D(3) were 0.45microM and 0.97min(-1), respectively. The k(cat)/K(m) value of CYP2R1 was 26-fold higher than that of CYP27A1. These results strongly suggest that CYP2R1 plays a physiologically important role in the vitamin D 25-hydroxylation in humans.

Citing Articles

A short review: the biological activity of vitamin D and its decomposition products.

Shimomura H, Wanibuchi K, Hosoda K, Amgalanbaatar A, Shoji M, Hayashi S Mol Biol Rep. 2025; 52(1):214.

PMID: 39921794 DOI: 10.1007/s11033-025-10322-8.


Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.

Wilson T, Zishiri O Cancer Rep (Hoboken). 2024; 7(10):e70016.

PMID: 39410867 PMC: 11480670. DOI: 10.1002/cnr2.70016.


The Association Between CYP2R1 rs10741657 Polymorphisms and Bone Variables, Vitamin D, and Calcium in Iranian Children and Adolescents: A Cross-Sectional Study.

Montazeri-Najafabady N, Dabbaghmanesh M Biochem Genet. 2024; .

PMID: 38834820 DOI: 10.1007/s10528-024-10826-1.


Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases.

Fenizia S, Gaggini M, Vassalle C Int J Mol Sci. 2023; 24(23).

PMID: 38069444 PMC: 10706901. DOI: 10.3390/ijms242317123.


Molecular Mechanisms Provide a Landscape for Biomarker Selection for Schizophrenia and Schizoaffective Psychosis.

Fryar-Williams S, Strobel J, Clements P Int J Mol Sci. 2023; 24(20).

PMID: 37894974 PMC: 10607016. DOI: 10.3390/ijms242015296.